Skip to content

Hutchmed (China)

US · HCM #2639 by market cap Listed 2016
13.22 -0.23 -1.71%
Periodic snapshot; not a real-time feed. · 2026-11-20 16:10

About Hutchmed (China)

HUTCHMED (China) Ltd. is a holding company, which engages in the research and development, manufacture, and sale of pharmaceuticals and health-oriented consumer products. It operates through the Oncology/Immunology and Other Ventures segments. The Oncology/Immunology segment includes the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The Other Ventures segment involves the other commercial businesses which include the sales, marketing, manufacture, and distribution of prescription drugs and healthcare products. The company was founded on December 18, 2000 and is headquartered in Hong Kong.

Founded
2000
CEO
Mr. Johnny Cheng Chig FUNG
Employees
1,796
Headquarters
Hong Kong,China, HK, China
Fiscal year end
12-31
Website
hutch-med.com

Company profile

Exchange
US
Symbol
HCM
Market-cap rank
#2639
Listing date
2016-03-17
Market cap
2.31B
Float cap
1.39B
Shares out
174.47M
Float shares
105.22M

Sectors & themes

Best Growth Stocks Drug Manufacturers - Specialty & Generic HK ADR Fractional Shares JP Chinese Concept

Browse all sectors & themes

Quote time 2026-11-20 16:10:04 · For reference only, not investment advice and not tailored to your situation.

Hutchmed (China) discussion 0 comments

Add a comment